title: The choice of antigen for therapeutic immunization against AIDS.
abstract: Vaccination with Rev and Tat can induce or boost immune responses that control HIV more effectively than those generated in the context of a natural infection.
authors.forename: Carel A
authors.initials: CA
authors.lastname: van Baalen
authors.forename: Koert J
authors.initials: KJ
authors.lastname: Stittelaar
authors.forename: Albert D M E
authors.initials: AD
authors.lastname: Osterhaus
authors.forename: Christophe
authors.initials: C
authors.lastname: Guillon
authors.forename: Rob A
authors.initials: RA
authors.lastname: Gruters
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000276:immunology* / Q000628:therapy*; D023241:Antiretroviral Therapy, Highly Active; D015488:HIV Antigens; D006801:Humans; D007114:Immunization; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
chemical_list: D015488:HIV Antigens